Blocking PRMT5 might force resistant brain-tumor cells into senescence, study suggests

Posted by on June 13, 2016 1:03 pm
Categories: health

Blocking an enzyme called PRMT5 in tumor cells could be a promising new strategy for the treatment of glioblastoma, the most aggressive and lethal form of brain cancer, a new study suggests.

Leave a Reply

Your email address will not be published. Required fields are marked *